Precision medicine program for diabetes in China
Official title: Precision Medicine of Diabetes Program in China
Run by Second Xiangya Hospital of Central South University · NCT06320600 · Data updated 2026-11-12
This study is testing a new way to better classify and diagnose diabetes in patients in China to help create more personalized treatment plans.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 120000 (estimated) |
| Sponsor | Second Xiangya Hospital of Central South University Academic / other |
| Locations | 1 site (Changsha, Hunan) |
| Status | Recruiting |
| Started | July 1, 2023 |
| Main results expected | December 2028 |
| Study ends | December 2028 |
| Registry record updated | March 20, 2024 |
| Trial ID | NCT06320600 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients diagnosed with diabetes according to WHO 1999 criteria.
✕Probably not a fit
Patients who have had diabetes for more than one year or those without a proper medical history may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to enhance the precision classification and diagnosis of diabetes patients by utilizing both retrospective and prospective cohort studies. It seeks to establish a model for accurate diabetes classification and diagnosis, leveraging big data and multi-omics analysis to explore the underlying pathogenesis of diabetes. The goal is to improve individualized treatment approaches and predictive methods for managing diabetes effectively.
Why it matters
Potential benefit: If successful, this program could lead to more accurate diagnoses and personalized treatment plans for diabetes patients.
How similar studies have gone: Other studies focusing on precision medicine in diabetes have shown promise, indicating that this approach could yield beneficial results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed with diabetes according to WHO 1999 criteria Exclusion Criteria: * with duration more than 1 year; Diabetes has not been diagnosed by WHO standards in 1999; Absence of medical history data
Where it's running
-
the Second Xiangya Hospital
Changsha, Hunan, China Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
New virtual care pathway for older adults with chronic diseases
A teleconsultation-based care pathway for adults 60+ with hypertension, diabetes, or dyslipidemia to see if it’s feasible and cost-saving in Malaysian primary care compared with usual clinic visits.
-
Benefits of Retained Insulin for Good Health in Diabetes
This study tests whether preserving or restoring a person’s own insulin production can improve quality of life and blood sugar control for people who need insulin to manage diabetes.
-
Improving Care for underserved older Black patients with cardiovascular and other chronic conditions
This study tests a culturally tailored approach to patient-centered care for older African American patients with cardiovascular disease and other conditions who receive care at a community hospital.
-
Myokines in metabolic and endocrine diseases linked to sarcopenia
This study tests whether myokines can serve as biomarkers or drivers of sarcopenia and sarcopenic obesity in people with metabolic or endocrine diseases.
-
Miniature breath sensors to detect hypo- and hyperglycemia in young people with diabetes
A small breath-sensor device will try to see if specific breath compounds can signal low or high blood sugar in youths with diabetes.
-
Polypill Approach for Multiple Cardiovascular Risk Factors
Researchers are testing a fixed-dose pill strategy to help people aged 50–75 with high blood pressure, high cholesterol, and diabetes see if it lowers their heart-disease risk and reduces future events.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.